BioLingus (Cayman) Limited (SUBL)

BioLingus (Cayman) Limited will go public soon, but the exact IPO date is still unknown.

IPO Price

$20.00

Shares Offered

360,000

Deal Size

$7.20M

SUBL Cash Flow Statement

Financials in millions USD. Fiscal year is May - April.

Millions USD. Fiscal year is May - Apr.

Year Ending	TTM	Apr 30, 2022	Apr 30, 2021
Net Income	-0.58	-1.42	-2.03
Depreciation & Amortization	0.11	0.16	0.22
Other Operating Activities	0.15	0.71	0.16
Operating Cash Flow	-0.33	-0.55	-1.65
Debt Issued / Paid	-	0.62	1.66
Other Financing Activities	0.47	-	-
Financing Cash Flow	0.47	0.62	1.66
Net Cash Flow	0.14	0.07	0.01
Free Cash Flow	-0.33	-0.55	-1.65

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).